Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC | 
| Reactivities | Human, Chimpanzee | 
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC | 
| Reactivities | Human, Chimpanzee | 
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB | 
| Reactivities | Human, Chimpanzee, Goat, Sheep | 
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB | 
| Reactivities | Human, Chimpanzee, Goat, Sheep | 
Recombinant Anti-CD62L (Clone DREG-56)
| Applications | Bl, FC, IP, WB | 
| Reactivities | Human, Chimpanzee, Bovine | 
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC | 
| Reactivities | Human, Chimpanzee | 
Recombinant Anti-Fc gamma receptor III (Clone 3G8)
| Applications | Bl, FC, IHC, IP | 
| Reactivities | Human, Chimpanzee, Baboon, Cynomolgus, Monkey, Macaque, Marmoset | 
Recombinant Anti-CD62L (Clone DREG-56)
| Applications | Bl, FC, IP, WB | 
| Reactivities | Human, Chimpanzee, Bovine | 
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC | 
| Reactivities | Human, Chimpanzee | 
Recombinant Anti-Fc gamma receptor III (Clone 3G8)
| Applications | Bl, FC, IHC, IP | 
| Reactivities | Human, Chimpanzee, Baboon, Cynomolgus, Monkey, Macaque, Marmoset | 
